Geode Capital Management’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.6K | Hold |
|
|||||
|
2025
Q1 | $64.9K | Hold |
|
|||||
|
2024
Q4 | $129K | Buy |
|
|||||
|
2024
Q3 | $84.9K | Hold |
|
|||||
|
2024
Q2 | $77.5K | Hold |
|
|||||
|
2024
Q1 | $106K | Hold |
|
|||||
|
2023
Q4 | $92.4K | Buy |
|
|||||
|
2023
Q3 | $47.2K | Hold |
|
|||||
|
2023
Q2 | $58.8K | Hold |
|
|||||
|
2023
Q1 | $77.3K | Hold |
|
|||||
|
2022
Q4 | $134K | Hold |
|
|||||
|
2022
Q3 | $27K | Hold |
|
|||||
|
2022
Q2 | $28K | Hold |
|
|||||
|
2022
Q1 | $32K | Hold |
|
|||||
|
2021
Q4 | $290K | Hold |
|
|||||
|
2021
Q3 | $303K | Buy |
|
|||||
|
2021
Q2 | $171K | Buy |
|
|||||
|
2021
Q1 | $129K | Buy |
|
|||||
|
2020
Q4 | $56K | Sell |
|
|||||
|
2020
Q3 | $280K | Buy |
|
|||||
|
2020
Q2 | $336K | Buy |
|
|||||
|
2020
Q1 | $295K | Buy |
|
|||||
|
2019
Q4 | $525K | Buy |
|
|||||
|
2019
Q3 | $169K | Hold |
|
|||||
|
2019
Q2 | $268K | Hold |
|
|||||
|
2019
Q1 | $409K | Buy |
|
|||||
|
2018
Q4 | $302K | Buy |
|
|||||
|
2018
Q3 | $325K | Buy |
|
|||||
|
2018
Q2 | $81K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $59K | Sell |
|
|||||
|
2017
Q2 | $67K | Buy |
|
|||||
|
2017
Q1 | $57K | Buy |
|
|||||
|
2016
Q4 | $55K | Buy |
|
|||||
|
2016
Q3 | $73K | Buy |
|
|||||
|
2016
Q2 | $52K | Buy |
|